Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer

Clinical trial NCT03503344 · COMPLETED

Trial details

NCT number: NCT03503344
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma PSA Progression Stage IV Prostate Adenocarcinoma AJCC v7

Start date: 2019-12-17
Primary completion: 2024-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.